Disease Modifying Therapies

Medications are now available to slow the course of multiple sclerosis. These medications are called Disease Modifying Therapies (DMTs) or Disease Modifying Drugs (DMDs) because they slow the progression of multiple sclerosis.

• Deciding whether to use DMTs (PDF)

• Comparing the DMTs
  • Overview of the DMTs (PDF)
  • Table comparing DMTs (PDF)
  • Which DMT is the best?
    • Head to head studies of DMTs (PDF)
    • Comparing effects on MS attacks (PDF)
    • Comparing effects on disability (PDF)
    • Comparing effects on MRI (PDF)
    • Neutralizing antibodies (PDF)

• Information on each medication (PDFs)
  • Aubagio (Teriflunomide) 
  • Avonex (interferon beta-1a) 
  • Betaseron (interferon beta-1b) 
  • Copaxone (glatiramer acetate) 
  • Extavia (interferon beta-1b)
  • Gilenya (fingolimod) 
  • Glatopa 
  • Mavenclad
  • Mayzent
  • Mylan glatiramer acetate
  • Novantrone (mitoxantrone) 
  • Ocrevus (ocrelizumab) 
  • Plegridy
  • Rebif (interferon beta-1a) 
  • Tecfidera (BG-12, dimethyl fumarate) 
  • Tysabri (natalizumab) 
    • PML and Tysabri